1-5 of 5
Jingjing Cao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Parous Female Donor Is Not Inferior to Young Male Donor for Haploidentical Peripheral Blood Stem Cell Transplantation with Low-Dose ATG Plus Low-Dose Ptcy-Based Regimen for Gvhd Prophylaxis

Jingjing Cao, Chongmei Huang, Xingying Li, Yu Cai, Kun Zhou, Jun Yang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Ying Zhang, Xinxin Xia, Yu Wei, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song
Journal: Blood
Blood (2024) 144 (Supplement 1): 7388.
https://doi.org/10.1182/blood-2024-205154
Published: 2024
Journal Articles

Targeting B-Cell Malignancies with Anti-ROR1 CAR T-Cell Therapy

Jinsheng Weng, Cao Cuong Le, Yong Pan, Francesca Perutelli, Xiaoyun Cheng, Jingjing Cao, Owhofasa Agbedia, Shao-Qing Kuang, Jingwei Liu, Fuliang Chu, Sridevi Patchva, Neeraj Y. Saini, Sattva S. Neelapu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6827.
https://doi.org/10.1182/blood-2023-180028
Published: 2023
Journal Articles

Effect of Ivospemin and Difluoromethylornithine Polyamine Inhibitors on Viability of Myeloma Cell Lines

Abdur Rehman, Lubna Rehman, Krish Devnani, Cao Cuong Le, Chun-Yen Lin, Xiayoun Cheng, Fuliang Chu, Jinsheng Weng, Jingwei Liu, Sridevi Patchva, Shao-Qing Kuang, Jingjing Cao, Matthew Richard, Elizabeth Bruckheimer, Sattva S. Neelapu, Neeraj Y. Saini
Journal: Blood
Blood (2023) 142 (Supplement 1): 6589.
https://doi.org/10.1182/blood-2023-189595
Published: 2023
Journal Articles

Targeting CAR T Resistance Due to CD19 Loss with CD79b-Specific CAR T Cells in B-Cell Malignancies

Fuliang Chu, PhD, Jinsheng Weng, MD PhD, Shao-Qing Kuang, PhD, Xiaoyun Cheng, JingJing Cao, Jingwei Liu, MD, Swathi Karri, Adithi Reddy, Sattva S. Neelapu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1662.
https://doi.org/10.1182/blood-2018-99-119009
Published: 2018
Journal Articles

High Complete Response Rates with Pembrolizumab in Combination with Rituximab in Patients with Relapsed Follicular Lymphoma: Results of an Open-Label, Phase II Study

Loretta Nastoupil, MD, Jason R. Westin, MD, Nathan H. Fowler, MD, Michelle A. Fanale, MD, Felipe Samaniego, MD, Yasuhiro Oki, MD, Ly Dsouza, PA-C, Chizobam Obi, RN, JingJing Cao, Xiaoyun Cheng, Man Chun John MA, PhD, Wang Zhiqiang, Lei Feng, MS, Shouhao Zhou, R. Eric Davis, MD, Sattva S. Neelapu, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 414.
https://doi.org/10.1182/blood.V130.Suppl_1.414.414
Published: 2017